Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2024 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

mckesson corp. - MCK

MCK

Close Chg Chg %
621.27 6.84 1.10%

Pre-Market

628.11

+6.84 (1.10%)

Volume: 499.08K

Last Updated:

Nov 21, 2024, 3:59 PM EDT

Trade Now

Company Overview: mckesson corp. - MCK

MCK Key Data

Open

$621.07

 Day Range

616.98 - 629.73

52 Week Range

431.35 - 637.51

 Market Cap

$78.85B

Shares Outstanding

126.94M

 Public Float

126.80M

Beta

0.44

 Rev. Per Employee

N/A

P/E Ratio

32.19

 EPS

$19.42

Yield

41.38%

 Dividend

$0.71

EX-DIVIDEND DATE

Dec 2, 2024

 SHORT INTEREST

N/A

AVERAGE VOLUME

927.63K

  

MCK Performance

1 Week
 
 3.63%
 
1 Month
 
 23.82%
 
3 Months
 
 13.79%
 
1 Year
 
 36.17%
 
5 Years
 
 311.68%
 

MCK Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 20
Full Ratings ➔

About mckesson corp. - MCK

McKesson Corp. engages in providing healthcare services. It operates through the following segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs. The RxTS segment offers prescription price transparency, benefit insight, dispensing support services, third-party logistics, and wholesale distribution. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The International segment refers to the distribution and services to wholesale, institutional, and retail customers in Europe and Canada. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Irving, TX.

MCK At a Glance

McKesson Corp.
6555 State Highway 161
Irving, Texas 75039
Phone 1-972-446-4800 Revenue 308.95B
Industry Medical Distributors Net Income 3.00B
Sector Distribution Services 2024 Sales Growth 11.651%
Fiscal Year-end 03 / 2025 Employees 51,000
View SEC Filings

MCK Valuation

P/E Current 32.194
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 23.981
Price to Sales Ratio 0.233
Price to Book Ratio N/A
Price to Cash Flow Ratio 16.688
Enterprise Value to EBITDA 16.477
Enterprise Value to Sales 0.243
Total Debt to Enterprise Value 0.098

MCK Efficiency

Revenue/Employee 6,057,862.745
Income Per Employee 58,862.745
Receivables Turnover 14.289
Total Asset Turnover 4.762

MCK Liquidity

Current Ratio 0.916
Quick Ratio 0.512
Cash Ratio 0.088

MCK Profitability

Gross Margin 3.949
Operating Margin 1.271
Pretax Margin 1.226
Net Margin 0.972
Return on Assets 4.627
Return on Equity N/A
Return on Total Capital 55.398
Return on Invested Capital 64.943

MCK Capital Structure

Total Debt to Total Equity N/A
Total Debt to Total Capital 136.372
Total Debt to Total Assets 10.957
Long-Term Debt to Equity N/A
Long-Term Debt to Total Capital 130.006
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Mckesson Corp. - MCK

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
238.23B 263.97B 276.71B 308.95B
Sales Growth
+3.11% +10.80% +4.83% +11.65%
Cost of Goods Sold (COGS) incl D&A
226.65B 251.32B 264.84B 296.75B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
1.22B 1.00B 857.00M 635.00M
Depreciation
655.00M 520.00M 497.00M 253.00M
Amortization of Intangibles
566.00M 481.00M 360.00M 382.00M
COGS Growth
+3.18% +10.89% +5.38% +12.05%
Gross Income
11.58B 12.65B 11.87B 12.20B
Gross Income Growth
+1.60% +9.21% -6.17% +2.81%
Gross Profit Margin
+4.86% +4.79% +4.29% +3.95%
2021 2022 2023 2024 5-year trend
SG&A Expense
8.07B 9.93B 7.42B 8.28B
Research & Development
74.00M 70.00M 89.00M 77.00M
Other SG&A
8.00B 9.86B 7.33B 8.20B
SGA Growth
-3.77% +22.97% -25.29% +11.58%
Other Operating Expense
- - - -
-
Unusual Expense
8.55B 876.00M (257.00M) 51.00M
EBIT after Unusual Expense
(5.04B) 1.85B 4.71B 3.88B
Non Operating Income/Expense
223.00M 259.00M 168.00M 156.00M
Non-Operating Interest Income
12.00M 10.00M 107.00M 118.00M
Equity in Earnings of Affiliates
48.00M 43.00M 5.00M 4.00M
Interest Expense
217.00M 178.00M 248.00M 243.00M
Interest Expense Growth
-12.85% -17.97% +39.33% -2.02%
Gross Interest Expense
217.00M 178.00M 248.00M 243.00M
Interest Capitalized
- - - -
-
Pretax Income
(5.03B) 1.93B 4.63B 3.79B
Pretax Income Growth
-540.03% +138.30% +140.15% -18.16%
Pretax Margin
-2.11% +0.73% +1.67% +1.23%
Income Tax
(695.00M) 636.00M 905.00M 629.00M
Income Tax - Current - Domestic
32.00M 362.00M 745.00M 1.10B
Income Tax - Current - Foreign
181.00M 240.00M 180.00M 134.00M
Income Tax - Deferred - Domestic
(766.00M) 72.00M (10.00M) (493.00M)
Income Tax - Deferred - Foreign
(142.00M) (38.00M) (10.00M) (110.00M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
48.00M 43.00M 5.00M 4.00M
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(4.34B) 1.29B 3.73B 3.16B
Minority Interest Expense
199.00M 173.00M 162.00M 158.00M
Net Income
(4.54B) 1.12B 3.56B 3.00B
Net Income Growth
-600.88% +124.66% +218.41% -15.75%
Net Margin Growth
-1.90% +0.42% +1.29% +0.97%
Extraordinaries & Discontinued Operations
- (1.00M) (5.00M) (3.00M)
Discontinued Operations
- (1.00M) (5.00M) (3.00M)
Net Income After Extraordinaries
(4.54B) 1.11B 3.56B 3.00B
Preferred Dividends
- - - -
-
Net Income Available to Common
(4.54B) 1.11B 3.56B 3.00B
EPS (Basic)
-28.2628 7.3145 25.2303 22.5375
EPS (Basic) Growth
-668.39% +125.88% +244.94% -10.67%
Basic Shares Outstanding
160.60M 152.30M 141.10M 133.20M
EPS (Diluted)
-28.2628 7.2291 25.0352 22.3863
EPS (Diluted) Growth
-671.54% +125.58% +246.31% -10.58%
Diluted Shares Outstanding
160.60M 154.10M 142.20M 134.10M
EBITDA
4.73B 3.72B 5.31B 4.56B
EBITDA Growth
+20.26% -21.29% +42.59% -14.09%
EBITDA Margin
+1.99% +1.41% +1.92% +1.48%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 644.80
Number of Ratings 20 Current Quarters Estimate 8.445
FY Report Date 12 / 2024 Current Year's Estimate 32.623
Last Quarter’s Earnings 7.07 Median PE on CY Estimate N/A
Year Ago Earnings 27.44 Next Fiscal Year Estimate 36.612
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 16 16 17 16
Mean Estimate 8.44 9.27 32.62 36.61
High Estimates 8.92 10.22 32.90 37.89
Low Estimate 7.53 8.79 31.90 34.85
Coefficient of Variance 3.78 3.63 0.81 1.94

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 12 13 12
OVERWEIGHT 3 2 4
HOLD 5 4 2
UNDERWEIGHT 0 1 1
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Mckesson Corp. - MCK

Date Name Shares Transaction Value
Jun 13, 2024 LeAnn B. Smith EVP & Chief HR Officer 2,022 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $585.53 per share 1,183,941.66
Jun 12, 2024 Maria Martinez Director N/A Open market or private sale of non-derivative or derivative security Non-derivative transaction at $585.88 per share 0.00
Jun 7, 2024 Brian Scott Tyler Chief Executive Officer; Director 89,845 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $574.41 per share 51,607,866.45
Jun 5, 2024 Deborah L. Dunsire Director 56 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jun 4, 2024 Tom Rodgers EVP, Chief Strategy & BDO 2,544 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $560.99 per share 1,427,158.56
May 30, 2024 Tom Rodgers EVP, Chief Strategy & BDO 7,776 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $550 per share 4,276,800.00
May 30, 2024 LeAnn B. Smith EVP & Chief HR Officer N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 30, 2024 Britt J. Vitalone EVP & CFO 15,905 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $560.73 per share 8,918,410.65
May 30, 2024 Britt J. Vitalone EVP & CFO 16,544 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 30, 2024 Britt J. Vitalone EVP & CFO 18,286 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 30, 2024 Brian Scott Tyler Chief Executive Officer; Director 92,236 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $560.73 per share 51,719,492.28
May 30, 2024 Tom Rodgers EVP, Chief Strategy & BDO N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 30, 2024 Tom Rodgers EVP, Chief Strategy & BDO 588 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 30, 2024 Brian Scott Tyler Chief Executive Officer; Director 100,569 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 30, 2024 Tom Rodgers EVP, Chief Strategy & BDO 7,909 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $557.4 per share 4,408,476.60
May 30, 2024 Tom Rodgers EVP, Chief Strategy & BDO 8,698 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $560.73 per share 4,877,229.54
May 30, 2024 Tom Rodgers EVP, Chief Strategy & BDO 9,047 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 30, 2024 Tom Rodgers EVP, Chief Strategy & BDO 8,162 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $560.73 per share 4,576,678.26
May 30, 2024 Brian Scott Tyler Chief Executive Officer; Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 30, 2024 Brian Scott Tyler Chief Executive Officer; Director 5,272 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00

Mckesson Corp. in the News